Cargando…
The role of PARP in DNA repair and its therapeutic exploitation
Historically, PARP inhibitors (PARPi) were developed to potentiate the cytotoxic effect of certain chemotherapeutic agents and are currently being investigated in combination with chemotherapy in diverse cancer types. These agents are also radiosensitisers and clinical trials of PARPi with concurren...
Autores principales: | Javle, M, Curtin, N J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208503/ https://www.ncbi.nlm.nih.gov/pubmed/21989215 http://dx.doi.org/10.1038/bjc.2011.382 |
Ejemplares similares
-
Exploiting inflammation for therapeutic gain in pancreatic cancer
por: Steele, C W, et al.
Publicado: (2013) -
Repair of radiation damage to DNA
por: Willers, H, et al.
Publicado: (2004) -
Exploiting the promiscuity of imatinib
por: Lee, Shun J, et al.
Publicado: (2009) -
Advances in using PARP inhibitors to treat cancer
por: Kummar, Shivaani, et al.
Publicado: (2012) -
The telomeric PARP, tankyrases, as targets for cancer therapy
por: Seimiya, H
Publicado: (2006)